Related Experiment Video
Updated: Oct 21, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Predicting and Preventing Acute Care Re-Utilization by Patients with Diabetes
Daniel J Rubin1, Arnav A Shah2
1Section of Endocrinology, Diabetes, and Metabolism, Lewis Katz School of Medicine at Temple University, 3322 N. Broad ST., Ste 205, Philadelphia, PA, 19140, USA. djrubin@temple.edu.
Diabetes patients frequently experience costly hospital readmissions and Emergency Department (ED) visits. While risk factors are known, interventions like education and care transitions show promise for reducing acute care re-utilization.
Area of Science:
- Healthcare Quality and Management
- Diabetes Care
- Health Services Research
Background:
- Acute care re-utilization, including hospital readmissions and post-discharge Emergency Department (ED) visits, significantly impacts healthcare costs and quality.
- Diabetes is a primary driver of this re-utilization and its associated expenses.
Purpose of the Study:
- To review the epidemiology of readmissions in diabetes patients.
- To describe existing models for predicting readmission risk.
- To discuss strategies for mitigating acute care re-utilization in this population.
Main Methods:
- Literature review of epidemiological data on diabetes-related readmissions.
- Analysis of predictive models for readmission risk.
- Synthesis of evidence on interventions aimed at reducing acute care re-utilization.
Main Results:
- Diabetes patients face high rates of readmission and ED use, influenced by factors like comorbidities and prior admissions.
- Existing predictive models offer moderate accuracy, with potential for improvement via machine learning.
- Interventions including inpatient education, care transition support, and outpatient follow-up show potential for reducing re-utilization, though more robust trials are needed.
Conclusions:
- Reducing acute care re-utilization in diabetes patients is crucial for improving healthcare quality and lowering costs.
- Enhanced predictive models and integrated clinical tools are needed for effective risk identification and management.
- Further multi-site randomized controlled trials are essential to validate the effectiveness and scalability of risk reduction interventions.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Acute Kidney Injury VI: Nursing Management
Preventive Healthcare Services
Chronic Kidney Disease IV: Nursing Management

